Literature DB >> 15761490

Sentinel node micrometastasis in breast carcinoma may not be an indication for complete axillary dissection.

Heather Rutledge1, Joseph Davis, Ronald Chiu, Michael Cibull, Yolanda Brill, Patrick McGrath, Luis Samayoa.   

Abstract

The decision whether to proceed with complete axillary node dissection based on sentinel node status is clear for patients with negative or macrometastatic disease. However, the course of action based on sentinel node micrometastasis remains controversial. We reviewed 358 cases from 6/1999 to 7/2003. All sentinel nodes were evaluated at three levels by frozen section, touch preparation, and scrape preparation. Micrometastasis was defined as tumor deposits between 0.2 and 2 mm. Size, grade, and lymphvascular invasion of the primary tumor, as well as number, status, size of metastatic disease, and presence of extranodal capsular extension of sentinel and nonsentinel nodes were recorded. Of the 358 cases, 89 had positive sentinel nodes, 29 of which represented micrometastases. Only one (3%) of the 29 cases contained a nonsentinel node with macrometastasis. In 60 of the 89 cases sentinel nodes contained macrometastases. Of these, 38 cases (63%) had metastatic tumor in nonsentinel nodes. Intraoperative consult was performed in 53 of the 89 cases with positive sentinel nodes. Only 1 of the 19 (5%) intraoperative consult cases with micrometastatic sentinel nodes had positive nonsentinel nodes, while 21 of 34 (62%) of macrometastatic sentinel nodes at intraoperative consult had tumor in nonsentinel nodes. No single variable studied discriminated between micro- vs macrometastatic disease. At intraoperative consult, macrometastatic disease was present in all three diagnostic preparations, while diagnostic material in micrometastatic sentinel nodes was usually present in only one modality. This analysis suggests that the risk of finding tumor in nonsentinel nodes differs significantly between cases with micro (3%)- vs macro (63%)-metastatic disease in sentinel nodes. This holds true for cases assessed by intraoperative consult. Considering the known morbidity of complete axillary dissection, assessments of risk vs benefit of undertaking this procedure should be performed on a case-by-case basis in patients with sentinel node micrometastases.

Entities:  

Mesh:

Year:  2005        PMID: 15761490     DOI: 10.1038/modpathol.3800394

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  9 in total

1.  Validation of online calculators to predict the non-sentinel lymph node status in sentinel lymph node-positive breast cancer patients.

Authors:  Satoru Tanaka; Nayuko Sato; Hiroya Fujioka; Yuko Takahashi; Kosei Kimura; Mitsuhiko Iwamoto
Journal:  Surg Today       Date:  2012-06-22       Impact factor: 2.549

Review 2.  Breast cancer and sentinel lymph node micrometastases: indications for lymphadenectomy and literature review.

Authors:  G Zanghì; G Di Stefano; A Caponnetto; R Vecchio; A Lanaia; A La Terra; V Leanza; F Basile
Journal:  G Chir       Date:  2014 Nov-Dec

3.  Axillary Lymph Node Status in Early-Stage Breast Cancer Patients with Sentinel Node Micrometastases (0.2-2 mm).

Authors:  Johannes Bargehr; Michael Edlinger; Michael Hubalek; Christian Marth; Roland Reitsamer
Journal:  Breast Care (Basel)       Date:  2013-06       Impact factor: 2.860

4.  Prediction of involvement of sentinel and nonsentinel lymph nodes in a Canadian population with breast cancer.

Authors:  Ravi Ramjeesingh; May Lynn Quan; Sandra Gardner; Claire M B Holloway
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

Review 5.  Recent advances in the surgical care of breast cancer patients.

Authors:  Alessandra Mascaro; Massimo Farina; Raffaella Gigli; Carlo E Vitelli; Lucio Fortunato
Journal:  World J Surg Oncol       Date:  2010-01-20       Impact factor: 2.754

6.  Sentinel lymph node biopsy in breast cancer patients undergoing skin/nipple-sparing mastectomy and immediate autologous reconstruction.

Authors:  Satoru Tanaka; Takehiro Nohara; Mitsuhiko Iwamoto; Kazuhiro Sumiyoshi; Kosei Kimura; Yuko Takahashi; Nobuhiko Tanigawa
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

7.  Eight-year experience with the intraoperative frozen section examination of sentinel lymph node biopsy for breast cancer in a North-Italian university center.

Authors:  Carla Cedolini; Serena Bertozzi; Luca Seriau; Ambrogio P Londero; Serena Concina; Federico Cattin; Onelio Geatti; Carla Di Loreto; Andrea Risaliti
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

Review 8.  Clinical evidence of breast cancer micrometastasis in the era of sentinel node biopsy.

Authors:  Noriaki Wada; Shigeru Imoto
Journal:  Int J Clin Oncol       Date:  2008-02-29       Impact factor: 3.402

9.  Impact of Deep Learning Assistance on the Histopathologic Review of Lymph Nodes for Metastatic Breast Cancer.

Authors:  David F Steiner; Robert MacDonald; Yun Liu; Peter Truszkowski; Jason D Hipp; Christopher Gammage; Florence Thng; Lily Peng; Martin C Stumpe
Journal:  Am J Surg Pathol       Date:  2018-12       Impact factor: 6.394

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.